An interview with Alfredo Falcone and Lisa Salvatore: RECOURSE and trifluridine/tipiracil in metastatic colorectal cancer. (September 2016)

• Record Type: Journal Article
• Authors: Falcone, Alfredo; Salvatore, Lisa
• Is Part Of: Future oncology. Volume 12:Number 18(2016)
• Page Start: 2065
• Page End: 2069
• Publication Date: 2016-09
• Subjects: Oncology -- Periodicals; 616.99405
• DOI: 10.2217/fon-2016-0249
• Languages: English
• ISSNs: 1479-6694

Abstract

Professor Alfredo Falcone and Dr Lisa Salvatore speak to Roshaine Gunawardana, Managing Commissioning Editor: Professor Alfredo Falcone is the Director of the Department of Oncology and the Specialization School at the University Hospital of Pisa, Italy. He trained in Pisa and Genoa, Italy, and has held major positions in Italian oncology since 2000. He currently has more than 300 publications, including papers in peer-reviewed international and national journals, book chapters, and more than 600 abstracts of presentations to international and national conferences. The majority of his papers regard clinical and translational research, with a particular focus on metastatic colorectal cancer. Dr Lisa Salvatore is a medical oncologist in the Department of Translational Research and New Technologies in Medicine and Surgery at the University of Pisa. She has been an author on about 40 publications in major peer-reviewed publications and has made numerous presentations in national and international conferences. Her main interest is focused on clinical and translational research in metastatic colorectal cancer.